Carmichael Hill & Associates’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$574K Buy
19,850
+219
+1% +$6.34K 0.2% 87
2024
Q2
$549K Buy
19,631
+17
+0.1% +$476 0.22% 81
2024
Q1
$544K Buy
19,614
+2,500
+15% +$69.4K 0.22% 82
2023
Q4
$493K Sell
17,114
-620
-3% -$17.9K 0.2% 84
2023
Q3
$588K Buy
17,734
+558
+3% +$18.5K 0.27% 69
2023
Q2
$630K Buy
17,176
+1,657
+11% +$60.8K 0.28% 70
2023
Q1
$633K Buy
15,519
+518
+3% +$21.1K 0.31% 68
2022
Q4
$769K Sell
15,001
-655
-4% -$33.6K 0.39% 57
2022
Q3
$685K Buy
15,656
+105
+0.7% +$4.59K 0.37% 60
2022
Q2
$815K Buy
15,551
+907
+6% +$47.5K 0.43% 51
2022
Q1
$758K Sell
14,644
-438
-3% -$22.7K 0.35% 60
2021
Q4
$891K Buy
15,082
+11
+0.1% +$650 0.4% 49
2021
Q3
$648K Buy
15,071
+146
+1% +$6.28K 0.32% 60
2021
Q2
$584K Buy
14,925
+157
+1% +$6.14K 0.3% 66
2021
Q1
$535K Buy
14,768
+270
+2% +$9.78K 0.29% 70
2020
Q4
$534K Sell
14,498
-637
-4% -$23.5K 0.31% 65
2020
Q3
$527K Buy
15,135
+424
+3% +$14.8K 0.35% 55
2020
Q2
$456K Buy
14,711
+580
+4% +$18K 0.34% 62
2020
Q1
$438K Sell
14,131
-305
-2% -$9.45K 0.38% 55
2019
Q4
$537K Buy
14,436
+693
+5% +$25.8K 0.38% 59
2019
Q3
$468K Sell
13,743
-211
-2% -$7.19K 0.46% 60
2019
Q2
$574K Sell
13,954
-240
-2% -$9.87K 0.57% 52
2019
Q1
$572K Sell
14,194
-793
-5% -$32K 0.59% 49
2018
Q4
$621K Sell
14,987
-1,007
-6% -$41.7K 0.71% 44
2018
Q3
$669K Buy
15,994
+10
+0.1% +$418 0.65% 48
2018
Q2
$550K Sell
15,984
-76
-0.5% -$2.62K 0.59% 52
2018
Q1
$541K Sell
16,060
-881
-5% -$29.7K 0.59% 53
2017
Q4
$582K Buy
+16,941
New +$582K 0.64% 49